Breast Biopsy Devices Market by Procedure Type, Product, and Guidance Type - Global Industry Analysis and Forecast to 2027
Published On : October 2017 Pages : 127 Category: Medical Devices Report Code : CM10250
Industry Outlook and Trend Analysis
It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques. The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame. For example, C.R Bard's Mission Truguide disposable coaxial biopsy needles, made of ultrathin walls, give high effectiveness and precision in the securing of sample tissue. Nonetheless, the dangers engaged with the methodology are probably going to influence the Breast Biopsy Device Market contrarily. The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.
Procedure Type Outlook and Trend Analysis
Based on the type of the procedure, this market industry is categorized into open surgical and needle breast biopsies. The latter is additionally classified into core-needle biopsy, fine-needle biopsy and vacuum-assisted Biopsy. Owing to the ascending demand for minimally invasive procedures, in 2017 the fine-needle aspiration segment was accountable for a greater marker share. Fine-needle aspiration biopsy is the simplest form of breast biopsy done and mostly performed to rule out lump which can be felt at the time of clinical breast exam. The procedure involves thin needle (with syringe) being directly injected into the lump to collect cell samples. On the other hand, due to the less-invasive nature of the procedure, the vacuum-assisted core biopsy is expected to bud at a considerable higher CAGR during the forecast period. The procedure involves a minor incision through which the needle is injected, following which the sample is collected with the help of a vacuum-powered device. Also, core-needle biopsy is gradually being performed more as a breast biopsy and is anticipated to stay predominant sub-segment as compared to others. Owing to the invasiveness of open surgical breast biopsy, which are of two types, i.e., incisional and excisional breast biopsies, these procedures are less preferred unless in extreme cases. Incisional biopsy extracts a particular part from the suspicious area which is sufficient for diagnosis. Whereas, excisional biopsy removes complete part of the abnormal, tumor area, either with or without taking an edge of the normal breast tissue.
Product Outlook and Trend Analysis
The key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2017, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame. In needles, the fine needle aspiration makes use of a very small needle to remove cells or liquid from the abnormal part and the core needle make the use of a big hollow needle to extract one sample of the breast in every insertion. In localization wires a guide wire is put into the suspicious part to assist the surgeon to detect the lesion for surgical biopsy.
Guidance Type Outlook and Trend Analysis
The biopsy methods require guidance systems to find the irregularity or lumps in the breast area. The accessible guiding systems utilized for biopsies incorporate the magnetic resonance guided biopsies, ultrasound-guided, and mammography-guided stereotactic among others that guide with the technique in identifying and finding the existence of unusual cell developments. The mammography-guided portion adds to the biggest share in the industry. Nonetheless, the likelihood of false positive outcomes related with the imaging of breast tissues that are dense is generally high. The ultrasound-guided method yields more exact outcomes and is foreseen to witness the most striking development rate amid the forecast period.
Regional Outlook and Trend Analysis
North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2017 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2017, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2017, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.
Competitive Insights
Some major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp). These organizations are extensively inclined in the enhancement of new products, decreasing the cost of production and in implementing strategies like approvals from the Food and Drug Administration, acquisitions and mergers in order to upkeep their position in the industry. For example, Hologic, Inc declared its approval from the Food and Drug Administration for the Affirm Prone biopsy system that is commercially available. The new product is a guided system that is equipped with 2D/3D imaging characteristics.
The global Breast Biopsy Devices market is segmented as follows:
By Procedure Type
- Needle Breast Biopsy
- Open Surgical Breast Biopsy
By Product
- Guidance Systems
- Biopsy Tables
- Localization Wires
- Biopsy Needles
- Others (Punches, Markers, Sutures)
By Guidance Type
- Ultrasound-guided Breast Biopsy
- Mammography-guided Stereotactic Breast Biopsy
- Magnetic Resonance-guided Breast Biopsy
- Others (thermography, PET)
By Region
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Breast Biopsy Devices Market, By Procedure Type, Estimates and Forecast, 2017-2027 ($Million)
o Needle Breast Biopsy
o Open Surgical Breast Biopsy
o Breast Biopsy Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Guidance Systems
o Biopsy Tables
o Localization Wires
o Biopsy Needles
o Other Products
o Breast Biopsy Devices Market, By Guidance Type, Estimates and Forecast, 2017-2027 ($Million)
o Ultrasound-guided Breast Biopsy
o Mammography-guided Stereotactic Breast Biopsy
o Magnetic Resonance-guided Breast Biopsy
o Other Guidance Types
o Breast Biopsy Devices Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o C. R. Bard, Inc.
o Becton, Dickinson and Company (BD)
o Hologic, Inc.
o Devicor Medical Products, Inc.
o Stryker International, Inc.
o Argon Medical Devices, Inc.
o Cook Medical, Inc.
o Scion Medical Technologies, LLC.
o PLANMED OY
o OncoCyte Corporation
o F. Hoffmann-La Roche Ltd
o Laboratory Corporation of America® Holdings.
o Breast Biopsy Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Breast Biopsy Devices Market, By Country
o U.S. Breast Biopsy Devices Market
o Canada Breast Biopsy Devices Market
o Mexico Breast Biopsy Devices Market
o Europe
§ Europe Breast Biopsy Devices Market, By Country
o Germany Breast Biopsy Devices Market
o UK Breast Biopsy Devices Market
o France Breast Biopsy Devices Market
o Russia Breast Biopsy Devices Market
o Italy Breast Biopsy Devices Market
o Rest of Europe Breast Biopsy Devices Market
o Asia-Pacific
§ Asia-Pacific Breast Biopsy Devices Market, By Country
o China Breast Biopsy Devices Market
o Japan Breast Biopsy Devices Market
o South Korea Breast Biopsy Devices Market
o India Breast Biopsy Devices Market
o Southeast Asia Breast Biopsy Devices Market
o Rest of Asia-Pacific Breast Biopsy Devices Market
o South America
§ South America Breast Biopsy Devices Market, By Country
o Brazil Breast Biopsy Devices Market
o Argentina Breast Biopsy Devices Market
o Columbia Breast Biopsy Devices Market
o Rest of South America Breast Biopsy Devices Market
o Middle East and Africa
§ Middle East and Africa Breast Biopsy Devices Market, By Country
o Saudi Arabia Breast Biopsy Devices Market
o UAE Breast Biopsy Devices Market
o Egypt Breast Biopsy Devices Market
o Nigeria Breast Biopsy Devices Market
o South Africa Breast Biopsy Devices Market
o Rest of MEA Breast Biopsy Devices Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Breast Biopsy Devices Market, By Procedure Type
5.1. Introduction
5.2. Global Breast Biopsy Devices Revenue and Market Share by Procedure Type (2017-2027)
5.2.1. Global Breast Biopsy Devices Revenue and Revenue Share by Procedure Type (2017-2027)
5.3. Needle Breast Biopsy
5.3.1. Global Needle Breast Biopsy Revenue and Growth Rate (2017-2027)
5.4. Open Surgical Breast Biopsy
5.4.1. Global Open Surgical Breast Biopsy Revenue and Growth Rate (2017-2027)
6. Breast Biopsy Devices Market, By Product
6.1. Introduction
6.2. Global Breast Biopsy Devices Revenue and Market Share by Product (2017-2027)
6.2.1. Global Breast Biopsy Devices Revenue and Revenue Share by Product (2017-2027)
6.3. Guidance Systems
6.3.1. Global Guidance Systems Revenue and Growth Rate (2017-2027)
6.4. Biopsy Tables
6.4.1. Global Biopsy Tables Revenue and Growth Rate (2017-2027)
6.5. Localization Wires
6.5.1. Global Localization Wires Revenue and Growth Rate (2017-2027)
6.6. Biopsy Needles
6.6.1. Global Biopsy Needles Revenue and Growth Rate (2017-2027)
6.7. Other Products
6.7.1. Global Other Products Revenue and Growth Rate (2017-2027)
7. Breast Biopsy Devices Market, By Guidance Type
7.1. Introduction
7.2. Global Breast Biopsy Devices Revenue and Market Share by Guidance Type (2017-2027)
7.2.1. Global Breast Biopsy Devices Revenue and Revenue Share by Guidance Type (2017-2027)
7.3. Ultrasound-guided Breast Biopsy
7.3.1. Global Ultrasound-guided Breast Biopsy Revenue and Growth Rate (2017-2027)
7.4. Mammography-guided Stereotactic Breast Biopsy
7.4.1. Global Mammography-guided Stereotactic Breast Biopsy Revenue and Growth Rate (2017-2027)
7.5. Magnetic Resonance-guided Breast Biopsy
7.5.1. Global Magnetic Resonance-guided Breast Biopsy Revenue and Growth Rate (2017-2027)
7.6. Other Guidance Types
7.6.1. Global Other Guidance Types Revenue and Growth Rate (2017-2027)
8. Breast Biopsy Devices Market, By Region
8.1. Introduction
8.2. Global Breast Biopsy Devices Revenue and Market Share by Regions
8.2.1. Global Breast Biopsy Devices Revenue by Regions (2017-2027)
8.3. North America Breast Biopsy Devices by Countries
8.3.1. North America Breast Biopsy Devices Revenue and Growth Rate (2017-2027)
8.3.2. North America Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Breast Biopsy Devices by Countries
8.4.1. Europe Breast Biopsy Devices Revenue and Growth Rate (2017-2027)
8.4.2. Europe Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Breast Biopsy Devices by Countries
8.5.1. Asia-Pacific Breast Biopsy Devices Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Breast Biopsy Devices by Countries
8.6.1. South America Breast Biopsy Devices Revenue and Growth Rate (2017-2027)
8.6.2. South America Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Breast Biopsy Devices by Countries
8.7.1. Middle East and Africa Breast Biopsy Devices Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. C. R. Bard, Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Becton, Dickinson and Company (BD)
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Hologic, Inc.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Devicor Medical Products, Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Stryker International, Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Argon Medical Devices, Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Cook Medical, Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Scion Medical Technologies, LLC.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. PLANMED OY
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. OncoCyte Corporation
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
9.11. F. Hoffmann-La Roche Ltd
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Financial Overview
9.12. Laboratory Corporation of America® Holdings.
9.12.1. Business Overview
9.12.2. Service Portfolio
9.12.3. Strategic Developments
9.12.4. Financial Overview
10. Breast Biopsy Devices Market Forecast (2017-2027)
10.1. Global Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Breast Biopsy Devices Market Forecast by Regions (2017-2027)
10.2.1. North America Breast Biopsy Devices Market Forecast (2017-2027)
10.2.1.1. United States Breast Biopsy Devices Market Forecast (2017-2027)
10.2.1.2. Canada Breast Biopsy Devices Market Forecast (2017-2027)
10.2.1.3. Mexico Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2. Europe Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2.1. Germany Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2.2. France Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2.3. UK Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2.4. Russia Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2.5. Italy Breast Biopsy Devices Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3. Asia-Pacific Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3.1. China Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3.2. Japan Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3.3. Korea Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3.4. India Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Breast Biopsy Devices Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Breast Biopsy Devices Market Forecast (2017-2027)
10.2.4. South America Breast Biopsy Devices Market Forecast (2017-2027)
10.2.4.1. Brazil Breast Biopsy Devices Market Forecast (2017-2027)
10.2.4.2. Argentina Breast Biopsy Devices Market Forecast (2017-2027)
10.2.4.3. Columbia Breast Biopsy Devices Market Forecast (2017-2027)
10.2.4.4. Rest of South America Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5. Middle East and Africa Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.3. Egypt Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.4. Nigeria Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.5. South Africa Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.6. Turkey Breast Biopsy Devices Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Breast Biopsy Devices Market Forecast (2017-2027)
10.3. Breast Biopsy Devices Market Forecast by Procedure Type (2017-2027)
10.3.1. Breast Biopsy Devices Forecast by Procedure Type (2017-2027)
10.3.2. Breast Biopsy Devices Market Share Forecast by Procedure Type (2017-2027)
10.4. Breast Biopsy Devices Market Forecast by Product (2017-2027)
10.4.1. Breast Biopsy Devices Forecast by Product (2017-2027)
10.4.2. Breast Biopsy Devices Market Share Forecast by Product (2017-2027)
10.5. Breast Biopsy Devices Market Forecast by Guidance Type (2017-2027)
10.5.1. Breast Biopsy Devices Forecast by Guidance Type (2017-2027)
10.5.2. Breast Biopsy Devices Market Share Forecast by Guidance Type (2017-2027)
List of Tables
Figure United States Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Breast Biopsy Devices Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Breast Biopsy Devices Revenue and Revenue Share by Procedure Type (2017-2018)
Figure Global Needle Breast Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Open Surgical Breast Biopsy Revenue and Growth Rate (2017-2018)
Table Global Breast Biopsy Devices Revenue and Revenue Share by Product (2017-2018)
Figure Global Guidance Systems Revenue and Growth Rate (2017-2018)
Figure Global Biopsy Tables Revenue and Growth Rate (2017-2018)
Figure Global Localization Wires Revenue and Growth Rate (2017-2018)
Figure Global Biopsy Needles Revenue and Growth Rate (2017-2018)
Figure Global Other Products Revenue and Growth Rate (2017-2018)
Table Global Breast Biopsy Devices Revenue and Revenue Share by Guidance Type (2017-2018)
Figure Global Ultrasound-guided Breast Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Mammography-guided Stereotactic Breast Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Magnetic Resonance-guided Breast Biopsy Revenue and Growth Rate (2017-2018)
Figure Global Other Guidance Types Revenue and Growth Rate (2017-2018)
Table Global Breast Biopsy Devices Revenue by Regions (2017-2018)
Figure North America Breast Biopsy Devices Growth Rate (2017-2018)
Figure North America Breast Biopsy Devices Revenue and Growth Rate (2017-2018)
Figure North America Breast Biopsy Devices by Countries (2017-2018)
Figure North America Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2018)
Figure United States Breast Biopsy Devices Growth Rate (2017-2018)
Figure United States Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Breast Biopsy Devices Growth Rate (2017-2018)
Figure Canada Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Breast Biopsy Devices Growth Rate (2017-2018)
Figure Mexico Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Breast Biopsy Devices Growth Rate (2017-2018)
Figure Europe Breast Biopsy Devices Revenue and Growth Rate (2017-2018)
Figure Europe Breast Biopsy Devices by Countries (2017-2018)
Figure Europe Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2018)
Figure Germany Breast Biopsy Devices Growth Rate (2017-2018)
Figure Germany Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Breast Biopsy Devices Growth Rate (2017-2018)
Figure France Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Breast Biopsy Devices Growth Rate (2017-2018)
Figure UK Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Breast Biopsy Devices Growth Rate (2017-2018)
Figure Russia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Breast Biopsy Devices Growth Rate (2017-2018)
Figure Italy Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Breast Biopsy Devices Growth Rate (2017-2018)
Figure Rest of Europe Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Breast Biopsy Devices Growth Rate (2017-2018)
Figure Asia-Pacific Breast Biopsy Devices Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Breast Biopsy Devices by Countries (2017-2018)
Figure Asia-Pacific Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2018)
Figure China Breast Biopsy Devices Growth Rate (2017-2018)
Figure China Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Breast Biopsy Devices Growth Rate (2017-2018)
Figure Japan Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Breast Biopsy Devices Growth Rate (2017-2018)
Figure Korea Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Breast Biopsy Devices Growth Rate (2017-2018)
Figure India Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Breast Biopsy Devices Growth Rate (2017-2018)
Figure Southeast Asia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Breast Biopsy Devices Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Breast Biopsy Devices Growth Rate (2017-2018)
Figure South America Breast Biopsy Devices Revenue and Growth Rate (2017-2018)
Figure South America Breast Biopsy Devices by Countries (2017-2018)
Figure South America Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Breast Biopsy Devices Growth Rate (2017-2018)
Figure Brazil Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Breast Biopsy Devices Growth Rate (2017-2018)
Figure Argentina Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Breast Biopsy Devices Growth Rate (2017-2018)
Figure Columbia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Breast Biopsy Devices Growth Rate (2017-2018)
Figure Rest of South America Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Breast Biopsy Devices Growth Rate (2017-2018)
Figure Middle East and Africa Breast Biopsy Devices Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Breast Biopsy Devices by Countries (2017-2018)
Figure Middle East and Africa Breast Biopsy Devices Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Breast Biopsy Devices Growth Rate (2017-2018)
Figure Saudi Arabia Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Breast Biopsy Devices Growth Rate (2017-2018)
Figure United Arab Emirates Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Breast Biopsy Devices Growth Rate (2017-2018)
Figure Egypt Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Breast Biopsy Devices Growth Rate (2017-2018)
Figure Nigeria Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Breast Biopsy Devices Growth Rate (2017-2018)
Figure South Africa Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Breast Biopsy Devices Growth Rate (2017-2018)
Figure Turkey Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Breast Biopsy Devices Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Table C. R. Bard, Inc. Breast Biopsy Devices Financial Overview
Table Becton, Dickinson and Company (BD) Breast Biopsy Devices Financial Overview
Table Hologic, Inc. Breast Biopsy Devices Financial Overview
Table Devicor Medical Products, Inc. Breast Biopsy Devices Financial Overview
Table Stryker International, Inc. Breast Biopsy Devices Financial Overview
Table Argon Medical Devices, Inc. Breast Biopsy Devices Financial Overview
Table Cook Medical, Inc. Breast Biopsy Devices Financial Overview
Table Scion Medical Technologies, LLC. Breast Biopsy Devices Financial Overview
Table PLANMED OY Breast Biopsy Devices Financial Overview
Table OncoCyte Corporation Breast Biopsy Devices Financial Overview
Table F. Hoffmann-La Roche Ltd Breast Biopsy Devices Financial Overview
Table Laboratory Corporation of America® Holdings. Breast Biopsy Devices Financial Overview
Figure Global Breast Biopsy Devices Revenue (Millions USD) and Growth Rate (2018-2025)
Table Breast Biopsy Devices Market Forecast by Regions (2018-2025)
Figure North America Breast Biopsy Devices Market Forecast (2018-2025)
Figure United States Breast Biopsy Devices Market Forecast (2018-2025)
Figure Canada Breast Biopsy Devices Market Forecast (2018-2025)
Figure Mexico Breast Biopsy Devices Market Forecast (2018-2025)
Figure Europe Breast Biopsy Devices Market Forecast (2018-2025)
Figure Germany Breast Biopsy Devices Market Forecast (2018-2025)
Figure France Breast Biopsy Devices Market Forecast (2018-2025)
Figure UK Breast Biopsy Devices Market Forecast (2018-2025)
Figure Russia Breast Biopsy Devices Market Forecast (2018-2025)
Figure Italy Breast Biopsy Devices Market Forecast (2018-2025)
Figure Rest of Europe Breast Biopsy Devices Market Forecast (2018-2025)
Figure Asia-Pacific Breast Biopsy Devices Market Forecast (2018-2025)
Figure China Breast Biopsy Devices Market Forecast (2018-2025)
Figure Japan Breast Biopsy Devices Market Forecast (2018-2025)
Figure Korea Breast Biopsy Devices Market Forecast (2018-2025)
Figure India Breast Biopsy Devices Market Forecast (2018-2025)
Figure Southeast Asia Breast Biopsy Devices Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Breast Biopsy Devices Market Forecast (2018-2025)
Figure South America Breast Biopsy Devices Market Forecast (2018-2025)
Figure Brazil Breast Biopsy Devices Market Forecast (2018-2025)
Figure Argentina Breast Biopsy Devices Market Forecast (2018-2025)
Figure Columbia Breast Biopsy Devices Market Forecast (2018-2025)
Figure Rest of South America Breast Biopsy Devices Market Forecast (2018-2025)
Figure Middle East and Africa Breast Biopsy Devices Market Forecast (2018-2025)
Figure Saudi Arabia Breast Biopsy Devices Market Forecast (2018-2025)
Figure United Arab Emirates Breast Biopsy Devices Market Forecast (2018-2025)
Figure Egypt Breast Biopsy Devices Market Forecast (2018-2025)
Figure Nigeria Breast Biopsy Devices Market Forecast (2018-2025)
Figure South Africa Breast Biopsy Devices Market Forecast (2018-2025)
Figure Turkey Breast Biopsy Devices Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Breast Biopsy Devices Market Forecast (2018-2025)
Figure Global Breast Biopsy Devices Forecast by Procedure Type (2018-2025)
Figure Global Breast Biopsy Devices Market Share Forecast by Procedure Type (2018-2025)
Figure Global Breast Biopsy Devices Forecast by Procedure Type (2018-2025)
Figure Global Breast Biopsy Devices Forecast by Product (2018-2025)
Figure Global Breast Biopsy Devices Market Share Forecast by Product (2018-2025)
Figure Global Breast Biopsy Devices Forecast by Product (2018-2025)
Figure Global Breast Biopsy Devices Forecast by Guidance Type (2018-2025)
Figure Global Breast Biopsy Devices Market Share Forecast by Guidance Type (2018-2025)
Figure Global Breast Biopsy Devices Forecast by Guidance Type (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|